It was Glenn, a resident of the area Manchester Grand, he thinks "It will not be found alive"had it not been for the remarkable results achieved by immunotherapy, which is run by a local institution in Manchester linked to the National Health Service "NHS".
Information about rare cancer
Glenn was diagnosed with cholangiocarcinoma, a cancer that develops in the thin tubes that carry digestive bile fluid after eating to help digest fats. These tubes connect the liver to the gallbladder and small intestine.
Infections with this cancer are rare and usually occur in people over the age of 50.
This cancer works on the proliferation of cells lining the bile ducts more than normal, forming a tumor that invades and destroys healthy cells.
Every year, 1,000 people in Britain are diagnosed with bile duct cancer.
very difficult case
As for Glenn, whose cancer was spreading throughout his body, 1 in 50 people live for 5 years after being diagnosed with the malignant disease.
Doctors learned of Glen’s injury one day before his 49th birthday in June 2020, after he suffered severe pain in his shoulder, which made him unable to sleep.
Cancer began to spread in Glen’s body until it reached what he knew "Adrenal" And the liver, and the tumor has become so large that it is difficult to deal with it through surgical operations.
The tumor was classified as level four, amid very gloomy expectations for the near future.
Glenn said he asked the consultant doctor in charge of his condition how long he would live, and she told him frankly "12 months".
respite of hope
However, in the midst of this gloomy atmosphere, the process of transferring him to a new cancer program took place, where he participated in clinical trials for a treatment known as immunotherapy, which was approved for use in the treatment of other cancers such as lung, kidney, and others.
The idea of immunotherapy is to help the immune system recognize and attack cancer cells.
Pre-treatment screening showed that the patient’s tumor had a high mutation burden, indicating that he had a good response to treatment.
And the treatment of the patient, Glenn, relied on feeding his body with a liquid that helps the individual’s immune system to fight cancer, and the treatment also relied on chemical doses.
The treatment began to yield results, as the cancerous tumor in the liver shrank from 12 cm to 2.3 cm, while the cancerous tumor in the adrenal gland shrank from 7 cm to 4.1 cm.
This meant that Glenn was able to undergo surgery to remove the tumors.
The surprise was that the surgeons found only dead tissue, which means that the treatment eliminated the cancer cells.
He said the doctors checked the tumors twice but couldn’t believe what they saw, one of the nurses said "It’s a miracle".
Since the surgery he underwent last April, Glenn no longer needed additional treatments, and the following examinations showed that he had completely recovered from cancer.
“>
And the British newspaper “The Guardian” reported, on Friday, that Robert Glen, 51, had recovered from coronary artery disease cancer Wholly thanks to a new cure for this insidious disease known with immunotherapy.
It was Glenn, a resident of the area Manchester He believes that he “would not be alive”, had it not been for the remarkable results achieved by immunotherapy run by a local institution in Manchester linked to the National Health Service “NHS”.
Information about rare cancer
Glenn was diagnosed with cholangiocarcinoma, a cancer that develops in the thin tubes that carry digestive bile fluid after eating to help digest fats. These tubes connect the liver to the gallbladder and small intestine.
Infections with this cancer are rare and usually occur in people over the age of 50.
This cancer works on the proliferation of cells lining the bile ducts more than normal, forming a tumor that invades and destroys healthy cells.
Every year, 1,000 people in Britain are diagnosed with bile duct cancer.
very difficult case
As for Glenn, whose cancer was spreading throughout his body, 1 in 50 people live for 5 years after being diagnosed with the malignant disease.
Doctors learned of Glen’s injury one day before his 49th birthday in June 2020, after he suffered severe pain in his shoulder, which made him unable to sleep.
Cancer began to spread in Glenn’s body until it reached what is known as the “adrenal gland” and the liver, and the tumor became difficult to deal with through surgical operations.
The tumor was classified as level four, amid very gloomy expectations for the near future.
Glenn said he asked the consultant doctor in charge of his condition how long he would live, and she said bluntly, “12 months.”
respite of hope
However, in the midst of this gloomy atmosphere, the process of transferring him to a new cancer program took place, where he participated in clinical trials for a treatment known as immunotherapy, which was approved for use in the treatment of other cancers such as lung, kidney, and others.
The idea of immunotherapy is to help the immune system recognize and attack cancer cells.
Pre-treatment screening showed that the patient’s tumor had a high mutation burden, indicating that he had a good response to treatment.
And the treatment of the patient, Glenn, relied on feeding his body with a liquid that helps the individual’s immune system to fight cancer, and the treatment also relied on chemical doses.
The treatment began to yield results, as the cancerous tumor in the liver shrank from 12 cm to 2.3 cm, while the cancerous tumor in the adrenal gland shrank from 7 cm to 4.1 cm.
This meant that Glenn was able to undergo surgery to remove the tumors.
The surprise was that the surgeons found only dead tissue, which means that the treatment eliminated the cancer cells.
He said that the doctors checked the tumors twice, but they did not believe what they saw, and one of the nurses said, “It is a miracle.”
Since the surgery he underwent last April, Glenn no longer needed additional treatments, and the following examinations showed that he had completely recovered from cancer.